Trial intelligence / Profile preview

Sublingual misoprostol versus oxytocin to induce labor in term premature rupture of membranes

TCTR20200722003Phase 1Not yet recruiting

Sponsor
Bhumibol Adulyadej Hospital
Start
Jul 2020
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial in Rupture of amniotic membranes (PROM) comparing Sublingual misoprostol with Oxytocin (2 arms). Planned start Jul 2020; status: not yet recruiting.

02

Drugs

misoprostoloxytocin
03

Conditions

Rupture of amniotic membranes (PROM)

Beyond the preview

Go deeper on TCTR20200722003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200722003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call